Cutaneous T-cell lymphomas: the Sézary syndrome, mycosis fungoides, and related disorders.

Substantial evidence has accumulated to indicate not only that mycosis fungoides and the Sézary syndrome are closely related malignancies, but to suggest that they are part of a larger spectrum of cutaneous lymphomas. The neoplastic cells of these disorders have membrane features of thymus-derived (T) lymphocytes, a characteristic tissue distribution (skin infiltration, marrow sparing, localization in T-cell regions of lymphoid tissue), and distinctive morphology. For these reasons, we suggest that these lymphoproliferative disorders be grouped together as "cutaneous T-cell lymphomas". The anergy noted in patients of this group with leukemia probably is related to both decreased percentages of normal T cells and presence in the serum of macrophage migration inhibitory activity. Leukapheresis has been particularly effective in the management of selected patients. The homogeneous T-cell populations in the patients with leukemia also provide important opportunities to study many aspects of lymphocyte physiology that are of broad biologic significance.

[1]  T. Yoshida,et al.  Migration inhibitory activity in serum and cell supernatants in patients with Sezary syndrome. , 1975, Journal of Immunology.

[2]  P. Wiernik,et al.  MANAGEMENT OF MYCOSIS FUNGOIDES—CURRENT STATUS AND FUTURE PROSPECTS , 1975, Medicine.

[3]  L. Borella,et al.  E receptors on blasts from untreated acute lymphocytic leukemia (ALL): comparison of temperature dependence of E rosettes formed by normal and leukemic lymphoid cells. , 1975, Journal of immunology.

[4]  L. Thomas,et al.  Mycosis fungoides: The pathology of extracutaneous involvement , 1974, Cancer.

[5]  R. Blaese,et al.  INFECTIOUS AGAMMAGLOBULINEMIA: TRANSMISSION OF IMMUNODEFICIENCY WITH GRAFTS OF AGAMMAGLOBULINEMIC CELLS , 1974, The Journal of experimental medicine.

[6]  T. Waldmann,et al.  Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinaemia. , 1974, Lancet.

[7]  D. Variakojis,et al.  Mycosis fungoides: An ultrastructural study , 1974 .

[8]  H. Rappaport,et al.  Cytogenetic studies in mycosis fungoides , 1974, Cancer.

[9]  P. Schein,et al.  Successful management of the Sézary syndrome. Mobilization and removal of extravascular neoplastic T cells by leukapheresis. , 1974, The New England journal of medicine.

[10]  Winkelmann Rk Clinical studies of T-cell erythroderma in the Sezary syndrome. , 1974 .

[11]  D. Zucker‐Franklin Properties of the Sezary lymphoid cell. An ultrastructural analysis. , 1974, Mayo Clinic proceedings.

[12]  E. Shevach,et al.  Morphologic and functional properties of the atypical T lymphocytes of the Sezary syndrome. , 1974, Mayo Clinic proceedings.

[13]  D. Stites,et al.  ORIGIN OF HODGKIN'S CELL , 1974 .

[14]  A. Prieur,et al.  Membrane markers on chronic lymphocytic leukemia cells: A B cell leukemia with rosettes due to anti-sheep erythrocytes antibody activity of the membrane bound IgM and a T cell leukemia with surface Ig , 1974 .

[15]  M. Lutzner,et al.  Quantitative measurements of blood lymphocytes from patients with chronic lymphocytic leukemia and the Sézary syndrome. , 1974, Journal of the National Cancer Institute.

[16]  R. Castellino,et al.  Lymphography in mycosis fungoides , 1974, Cancer.

[17]  D. Variakojis,et al.  Mycosis fungoides: Pathologic findings in staging laparotomies , 1974, Cancer.

[18]  E. Shevach,et al.  Preferential cutaneous infiltration by neoplastic thymus-derived lymphocytes. Morphologic and functional studies. , 1974, Annals of internal medicine.

[19]  R. Parmley,et al.  IMMUNOHISTOCHEMICAL DEMONSTRATION OF IgG IN REED-STERNBERG AND OTHER CELLS IN HODGKIN'S DISEASE , 1974, The Journal of experimental medicine.

[20]  T. Yoshida,et al.  Serum migration-inhibitory activity in patients with lymphoproliferative diseases. , 1974, New England Journal of Medicine.

[21]  H. Gralnick,et al.  Nuclear topography in the abnormal cell of Sézary syndrome: observation by freeze-etch electron microscopy. , 1974, Journal of the National Cancer Institute.

[22]  T. Yoshida,et al.  Lymphokine activity in vivo in relation to circulating monocyte levels and delayed skin reactivity. , 1974, Journal of immunology.

[23]  E. Shevach,et al.  A human leukemia cell with both B and T cell surface receptors. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[24]  C. Kirkpatrick,et al.  Chemotactic activity in dialyzable transfer factor. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[25]  R. Gershon T cell control of antibody production. , 1974, Contemporary topics in immunobiology.

[26]  Z. Fuks,et al.  Prognostic signs and the management of the mycosis fungoides , 1973 .

[27]  C. Coltman,et al.  Therapy of mycosis fungoides with bleomycin , 1973, Cancer.

[28]  G. Flandrin,et al.  Indications of the thymus-derived nature of the proliferating cells in six patients with Sézary's syndrome. , 1973, The New England journal of medicine.

[29]  M. Frank,et al.  Identification of subpopulations of mononuclear cells in cutaneous infiltrates. I. Differentiation between B cells, T cells, and histiocytes. , 1973, The Journal of investigative dermatology.

[30]  R. Winkelmann,et al.  Erythroderma with atypical lymphocytes. (Sézary syndrome). , 1973, The American journal of medicine.

[31]  E. V. Van Scott,et al.  Complete remissions of mycosis fungoides lymphoma induced by topical nitrogen mustard (HN2). Control of delayed hypersensitivity to HN2 by desensitization and by induction of specific immunologic tolerance , 1973, Cancer.

[32]  Z. Bentwich,et al.  Lymphocyte binding of aggregated IgG and surface Ig staining in chronic lymphocytic leukaemia. , 1973, Clinical and experimental immunology.

[33]  I. Emerit,et al.  Cytogenetic, cytophotometric, and ultrastructural study of large cerebriform cells of the Sézary syndrome and description of a small-cell variant. , 1973, Journal of the National Cancer Institute.

[34]  V. Nussenzweig,et al.  Leukemic cells with membrane properties of thymus-derived (T) lymphocytes in a case of Sézary's syndrome: morphologic and immunologic studies. , 1973, Clinical immunology and immunopathology.

[35]  V. P. Eijsvoogel,et al.  The nature of the transforming lymphocyte in chronic lymphocytic leukemia , 1973 .

[36]  Hansen Mm Chronic lymphocytic leukaemia. Clinical studies based on 189 cases followed for a long time. , 1973 .

[37]  J. Preud’homme,et al.  Surface bound immunoglobulins as a cell marker in human lymphoproliferative diseases. , 1972, Blood.

[38]  C. Kirkpatrick,et al.  Effect of transfer factor on lymphocyte function in anergic patients. , 1972, The Journal of clinical investigation.

[39]  L. Díaz-Flores,et al.  CYTOLOGY OF THE MYCOSIS FUNGOIDES AND THE SÉZARY SYNDROME , 1972, The British journal of dermatology.

[40]  L. Old,et al.  SEROLOGICALLY DEMONSTRABLE ALLOANTIGENS OF MOUSE EPIDERMAL CELLS , 1972, The Journal of experimental medicine.

[41]  S. Hellman,et al.  Pathogenesis of Hodgkin's disease. , 1972, Lancet.

[42]  M. Lutzner,et al.  MYCOSIS FUNGOIDES: Survival, Prognostic Features, Response to Therapy, and Autopsy Findings , 1972, Medicine.

[43]  R. Schrek Ultrastructure of blood lymphocytes from chronic lymphocytic and lymphosarcoma cell leukemia. , 1972, Journal of the National Cancer Institute.

[44]  G. Achten,et al.  Bleomycin in mycosis fungoides and reticulum cell lymphoma. , 1971, Archives of dermatology.

[45]  R. Mcmillan,et al.  Lymphocytes and the immune response. I. , 1971, The New England journal of medicine.

[46]  B. Flaxman,et al.  Nonspecificity of characteristic cells in mycosis fungoides. , 1971, Archives of dermatology.

[47]  R. Gatti,et al.  Serum inhibitors of lymphocyte responses. , 1971, Lancet.

[48]  J. W. Hobbs,et al.  Ultrastructure of abnormal cells in Sezary syndrome, mycosis fungoides, and parapsoriasis en plaque. , 1971, Archives of dermatology.

[49]  P. Calabresi,et al.  Azaribine for mycosis fungoides. , 1971, Archives of dermatology.

[50]  P. Vincent,et al.  The Sézary syndrome: cytogenetic studies and identification of the Sézary Cell as an abnormal lymphocyte. , 1971, The American journal of medicine.

[51]  M. Frank,et al.  The effect of temperature on the reactivity of guinea-pig complement with gamma G and gamma M haemolytic antibodies. , 1970, Immunology.

[52]  R. Good Progress Toward A Cellular Engineering , 1970 .

[53]  V. Nussenzweig,et al.  Tissue localization of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. , 1970, Proceedings of the National Academy of Sciences of the United States of America.

[54]  T. Murad,et al.  Ultrastructure of mycosis fungoides , 1970, Cancer.

[55]  R. Seeger,et al.  SYNERGISTIC INTERACTION OF MACROPHAGES AND LYMPHOCYTES IN ANTIGEN-INDUCED TRANSFORMATION OF LYMPHOCYTES , 1970, The Journal of experimental medicine.

[56]  C. Abell,et al.  Effects of phytohemagglutinin and isoproterenol on DNA synthesis in lymphocytes from normal donors and patients with chronic lymphocytic leukemia. , 1970, Cancer research.

[57]  D. McFarlin,et al.  Impaired lymphocyte transformation in ataxia-telangiectasia in part due to a plasma inhibitory factor. , 1969, Journal of immunology.

[58]  H. Claman,et al.  Immunologic Complementation between Thymus and Marrow Cells—A Model for the Two‐Cell Theory of Immunocompetence , 1969, Transplantation reviews.

[59]  E. J. Field,et al.  Lymphocyte transformation in multiple sclerosis. Inhibition of unstimulated thymidine uptake by a serum factor. , 1968, Lancet.

[60]  M. Lutzner,et al.  The ultrastructure of an abnormal cell in Sézary's syndrome. , 1968, Blood.

[61]  E. M. Pantelouris,et al.  Absence of Thymus in a Mouse Mutant , 1968, Nature.

[62]  W. L. Macaulay Lymphomatoid papulosis. A continuing self-healing eruption, clinically benign--histologically malignant. , 1968, Archives of dermatology.

[63]  M. Silk Effect of plasma from patients with carcinoma on in vitro lymphocyte transformation , 1967, Cancer.

[64]  P. Carbone,et al.  Normal immunologic reactivity in patients with the lymphoma mycosis fungoides , 1966, Cancer.

[65]  R. Bottomley,et al.  Lactic dehydrogenase of human chronic lymphocytic leukemic leukocytes. , 1966, Blood.

[66]  R. H. Levin,et al.  Separation and collection of leukocytes. , 1965, Cancer research.

[67]  L. Tedeschi,et al.  Sézary syndrome. A malignant leukemic reticuloendotheliosis. , 1965, Archives of dermatology.

[68]  G. Brecher,et al.  Mycosis Fungoides: Relationship to Malignant Cutaneous Reticulosis and the Sézary Syndrome , 1964 .

[69]  A. Eisen,et al.  Mycosis fungoides: Natural history and aspects of its relationship to other malignant lymphomas , 1963 .

[70]  R. Winkelmann,et al.  Sezary syndrome--a malignant reticulemic erythroderma. , 1961, JAMA.

[71]  H. B. Goodall,et al.  SÉZARY'S SYNDROME. , 1959, The British journal of dermatology.

[72]  E. Epstein,et al.  DERMATOLOGIC MANIFESTATIONS OF THE LYMPHOBLASTOMA-LEUKEMIA GROUP , 1937 .